Literature DB >> 25903815

Autologous cell therapy: current treatments and future prospects .

Batool Kazmi1, Christopher J Inglefield, Mark P Lewis.   

Abstract

Autologous cell therapy (ACT) is a novel therapeutic intervention that uses an individual's cells, which are cultured and expanded outside the body, and reintroduced into the donor. Advantages of such an approach include the minimization of risks from systemic immunological reactions, bio-incompatibility, and disease transmission associated with grafts or cells not cultivated from the individual. So far, this form of therapy has been used successfully to bioengineer skin substitutes, aid wound healing, counteract chronic inflammation, treat burns and pressure ulcers, and improve postoperative healing. The authors will review the promising outcomes of various therapeutic interventions using ACT, as well as the concerns raised with using explanted material, and any potential alteration through the cultivation process. This review will discuss its role in assisting the healing process of conditions such as a damaged myocardium, developing hyaline cartilage, and in the treatment of neurodegenerative diseases and other ailments that benefit from the immediate availability of a donor. The use of ACT for cosmetic enhancement or corrective surgery is also gaining recognition as a creditable form of treatment and has been shown to reduce the risk of rejection and to have longer lasting effects than conventional treatments. This form of treatment is under intense investigation with the hope that it will eventually be able to replace conventional forms of plastic surgery to improve the repair process of aging or damaged tissues. .

Entities:  

Year:  2009        PMID: 25903815

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  4 in total

1.  Autologous fibroblasts for the treatment of cutaneous loxoscelism: First experience.

Authors:  Antonio Guglielmetti; Catalina Jahr; Matías Gompertz-Mattar
Journal:  Int Wound J       Date:  2019-09-17       Impact factor: 3.315

Review 2.  Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer.

Authors:  Ramanathan Karuppasamy; Shanthi Veerappapillai; Sayoni Maiti; Woong-Hee Shin; Daisuke Kihara
Journal:  Semin Cancer Biol       Date:  2019-11-04       Impact factor: 17.012

Review 3.  State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.

Authors:  Hosanna Brave; Ronan MacLoughlin
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

4.  One-Time Optimization of Advanced T Cell Culture Media Using a Machine Learning Pipeline.

Authors:  Paul Grzesik; Sebastian C Warth
Journal:  Front Bioeng Biotechnol       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.